New York, NY, Jul 8, 2020 — ConsenSys Health announced today the expansion of its Advisory Board with the appointment of six new members. This esteemed group of experts were selected to assist the leadership of the company for global impact in the areas of healthcare and life sciences.
A requirement to join the Advisory Board is a track record and a personal commitment to developing a more resilient and person-focused healthcare system. The Advisory Board members were chosen for their diverse backgrounds in technology, academia, care delivery, clinical operations, and public sector management.
“We consider this team to be critical to moving forward with our efforts to be the preeminent choice for global, evidence-based, ethics-driven technologies that drive positive and inclusive transformation in healthcare and the life sciences,” said Heather Leigh Flannery, Founder and Chief Executive Officer of ConsenSys Health. “Our Advisory Board will help transform the way we address the challenging times in which we live.”
The newest Advisory Board members for ConsenSys Health are:
Ntuthuko Bhengu, MB, ChB, DA, MBA, MPH
Health Management and Policy Expert, Founder of Alchemy Health Technologies
Founder of Avant Advisory
Lisa K. Fitzpatrick, MD, MPH, MPA
CEO and Founder of Grapevine Health, Clinical Professor at The George Washington School of Medicine and Health Sciences, Professorial Lecturer at The George Washington Milken Institute of Public Health
CEO and Founder of Hank AI
Associate Professor at the University of Utah School of Medicine, Research Scientist at the Salt Lake City VA Health Care System